MediXall (MDXL) Accounts Payables (2019 - 2024)
MediXall's Accounts Payables history spans 8 years, with the latest figure at $2.1 million for Q3 2024.
- For Q3 2024, Accounts Payables rose 42.63% year-over-year to $2.1 million; the TTM value through Sep 2024 reached $2.1 million, up 42.63%, while the annual FY2023 figure was $2.5 million, 130.12% up from the prior year.
- Accounts Payables reached $2.1 million in Q3 2024 per MDXL's latest filing, down from $2.9 million in the prior quarter.
- In the past five years, Accounts Payables ranged from a high of $2.9 million in Q2 2024 to a low of $477231.0 in Q2 2021.
- Average Accounts Payables over 5 years is $1.3 million, with a median of $973327.5 recorded in 2022.
- Peak YoY movement for Accounts Payables: fell 10.36% in 2022, then soared 130.12% in 2023.
- A 5-year view of Accounts Payables shows it stood at $571405.0 in 2020, then grew by 3.06% to $588870.0 in 2021, then surged by 86.82% to $1.1 million in 2022, then skyrocketed by 130.12% to $2.5 million in 2023, then fell by 18.53% to $2.1 million in 2024.
- Per Business Quant, the three most recent readings for MDXL's Accounts Payables are $2.1 million (Q3 2024), $2.9 million (Q2 2024), and $2.7 million (Q1 2024).